medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2016, Number 05

<< Back Next >>

Ginecol Obstet Mex 2016; 84 (05)

Active management of postpartum hemorrhage and Bakri balloon placement in primiparous and multiparous

Cruz-Cruz D, Peña-Dehesa H, Cérbulo-Vázquez A, Guzmán-López M

Language: Spanish
References: 34
Page: 279-286
PDF size: 571.77 Kb.


ABSTRACT

Objetive: To evaluate the usefulness of active management of the third stage of labor plus Bakri balloon in primiparous and multiparous patients with postpartum hemorrhage.
Material and Method:study in the Hospital of Women, from 1st January 2013 to 31st December 2014. We use uterotonics and after persistence of postpartum hemorrhage also considered Bakri balloon placement, and further transfusion management were evaluated. Analysis descriptive and inferential statistics were performed (Mann-Whitney U and linear regression) and the relationship between inter- and intra-group variables analyzed, a significance level of p ‹0.05 was established.
Results: We choice 47 patients (26 primiparous and 21 multiparous). The 100% of cases avoids obstetric hysterectomy, average age was lower in primiparous than multiparous (p ‹0.05). Both groups required transfusion of blood products at similar. The relationship between days of hospitalization vs bleeding volume was directly proportional to primiparous, but inversely proportional to the multiparous (p ‹0.05), the analysis for combinations of uterotonics in the management of postpartum hemorrhage, shown that misoprostol (800 mg, rectally) stressed this relationship in primiparous while effect disappears in multiparous.
Conclusion: The Bakri balloon placement decreases the number of fatalities and hysterectomies in obstetric patients in both primiparous and multiparous with postpartum hemorrhage that does not response to the treatment with uterotonic drugs.


REFERENCES

  1. 1 Neligan PJ, Laffey JG. Clinical review: special populations- critical illness and pregnancy. Critical care 2011;15(4):227.

  2. 2 Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth 2012;109(6):851-863.

  3. 3 Prata N, Bell S, Weidert K. Prevention of postpartum hemorrhage in low-resource settings: current perspectives. Int J Womens Health 2013;5:737-752.

  4. 4 Ng VK, Lo TK, Tsang HH, Lau WL, Leung WC. Intensive care unit admission of obstetric cases: a single centre experience with contemporary update. Hong Kong Med J 2014;20(1):24-31.

  5. 5 James AH, Kouides PA, Abdul-Kadir R, Dietrich JE, et al. Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel. Eur J Obstet Gynecol Reprod Biol 2011;158(2):124-34.

  6. 6 McLintock C, James AH. Obstetric hemorrhage. J Thromb Haemost 2011;9(8):441-1451.

  7. 7 American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 2006;108(4):1039- 1047.

  8. 8 Kong MC, To WW. Balloon tamponade for postpartum haemorrhage: case series and literature review. Hong Kong Med J 201;19:484-490.

  9. 9 Chandraharan E, Arulkumaran S. Surgical aspects of postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol 2008;22(6):1089-1102.

  10. 10 Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. The Cochrane Database of Syst Rev 2007;(1):CD003249.

  11. 11 Ortega-Castillo VM, Espino y Sosa S, Herrerias-Canedo T. [Obstetric hemorrhage control Bakri balloon]. Ginecol Obstet Mex 2013;81(8):435-439.

  12. 12 Leduc D, Senikas V, Lalonde AB, Ballerman C, et al. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can 2009;31(10):980-993.

  13. 13 Abdul-Kadir R, McLintok C, Ducloy AS, El-Refey H, et al. Evaluation and management of postpartum hemorrhage: consensus from an international expert panel. Transfusion 2014;54(7):1756-1768.

  14. 14 Bohlmann MK, Rath W. Medical prevention and treatment of postpartum hemorrhage: a comparison of different guidelines. Arch Gynecol Obstet 2014;289:555-567.

  15. 15 Gipson MG, Smith MT. Endovascular therapies for primary postpartum hemorrhage: techniques and outcomes. Sem Int Radiol 2013;30:333-339.

  16. 16 Danisman N, Kahyaoglu S, Celen S, Akselim B, et al. The outcomes of surgical treatment modalities to decrease “near miss” maternal morbidity caused by peripartum hemorrhage. Eur Rev Med Pharmacol Sci 2014;18(7):1092-1097.

  17. 17 Karateke A, Küçükbas M, Sozen H, Namazov A, et al. Fertility sparing surgery on placenta invasion anomalies and placenta previa. Iran J Reprod Med 2012;10(3):271-274.

  18. 18 Prata N, Passano P, Bell S, Rowen T, Potts M. New hope: community-based misoprostol use to prevent postpartum haemorrhage. Health Policy Plan 2013;28(4):339-346.

  19. 19 Smith JM, Gubin R, Holston MM, Fullerton J, Prata N. Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date. BMC Pregnancy Childbirth 2013;13:44.

  20. 20 Georgiou C. Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG 2009;116(6):748- 757.

  21. 21 Keriakos R, Mukhopadhyay A. The use of the Rusch balloon for management of severe postpartum haemorrhage. J Obstet Gynaecol 2006;26(4):335-8.

  22. 22 Johanson R, Kumar M, Obhrai M, Young P. Management of massive postpartum haemorrhage: use of a hydrostatic balloon catheter to avoid laparotomy. BJOG 2001;108:420- 422.

  23. 23 Japaraj RP, Raman S. Sengstaken-Blakemore tube to control massive postpartum haemorrhage. Med J Malaysia 2003;58(4):604-607.

  24. 24 Rishard MR, Galgomuwa GV, Gunawardane K. Improvised condom catheter with a draining channel for management of atonic post partum haemorrhage. Ceylon Med 2013;58(3):124-125.

  25. 25 Bakri YN. Uterine tamponade-drain for hemorrhage secondary to placenta previa-accreta. Int J Gynaecol Obstet 1992;37(4):302-303.

  26. 26 Machado LS. Emergency peripartum hysterectomy: Incidence, indications, risk factors and outcome. North Am J Med Sci 2001;3:358-361.

  27. 27 Elisa E. Pérdidas sanguíneas estimadas vs calculadas en hemorragia obstétrica. Médico Especialista en Ginecología y Obstetricia, Tesis, UNAM (2014).

  28. 28 Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anestha Analg 2010;110(5):1368- 1373.

  29. 29 Montufar-Rueda C, Rodriguez L, Jarquin JD, Barboza A, et al. Severe postpartum hemorrhage from uterine atony: a multicentric study. J Pregnancy 2013;525914.

  30. 30 Khan GQ, John IS, Wani S, Doherty T, Sibai BM. Controlled cord traction versus minimal intervention techniques in delivery of the placenta: a randomized controlled trial. Am J Obstet Gynecol 1997;177:770-774.

  31. 31 Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour. The Cochrane Database Syst Rev 2000;CD000007.

  32. 32 Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. The Cochrane Database Syst Rev 2013;CD001808.

  33. 33 McDonald S, Abbott JM, Higgins SP. Prophylactic ergometrine- oxytocin versus oxytocin for the third stage of labour. The Cochrane Database Syst Rev 2004;(1):CD000201.

  34. 34 el-Refaey H, O’Brien P, Morafa W, Walder J, Rodeck C. Misoprostol for third stage of labour. Lancet 1996;347(9010):1257.




2020     |     www.medigraphic.com